Opening Statements Set for Roger Clemens Perjury Trial

CNN on July 13, 2011 released the following:

“(CNN) — Opening statements are set to begin Wednesday in the perjury trial of former major league baseball player Roger Clemens.

On Tuesday, a jury of 10 women and two men — with four alternates — was seated for the federal trial in Washington, which is expected to last four to six weeks.

Clemens is facing charges of perjury, making false statements and obstruction of Congress about his alleged use of steroids and human growth hormone. The former all-star pitcher testified under oath in 2008 that he never used illegal performance-enhancing substances during his 23-year career.

The prosecution is expected to call several noteworthy figures to testify to bolster its case against the seven-time Cy Young award winner

Among those the prosecution expects to testify are former major league baseball players Barry Bonds, Mark McGwire, Jose Canseco and Andy Pettitte. The government also plans to call New York Yankees general manager Brian Cashman and Major League Baseball Commissioner Bud Selig to testify.

If convicted, Clemens could face a maximum sentence of 30 years in prison and a $1.5 million fine.

Clemens has never tested positive for drug use, but his name was among the 86 that appeared in a report by former Sen. George Mitchell. The 400-page report listed players who were said to have used drugs to improve their performance on the field.

Before the drug allegations against Clemens arose, he was seen as a first-ballot Hall of Famer. Now, as one of several players of the “steroid era,” his status for induction is seen as being in doubt.”

To find additional federal criminal news, please read The Federal Crimes Watch Daily.

Douglas McNabb and other members of the U.S. law firm practice and write extensively on matters involving Federal Criminal Defense, INTERPOL Red Notice Removal, International Extradition and OFAC SDN List Removal.

The author of this blog is Douglas McNabb. Please feel free to contact him directly at mcnabb@mcnabbassociates.com or at one of the offices listed above.

Bookmark and Share

Comments are closed.